Savant Capital LLC Has $264,000 Stock Holdings in Amdocs Limited (NASDAQ:DOX)

Savant Capital LLC grew its holdings in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 17.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,105 shares of the technology company’s stock after acquiring an additional 456 shares during the period. Savant Capital LLC’s holdings in Amdocs were worth $264,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in DOX. Creative Planning raised its holdings in Amdocs by 37.3% during the third quarter. Creative Planning now owns 15,111 shares of the technology company’s stock worth $1,322,000 after buying an additional 4,104 shares during the last quarter. Blue Trust Inc. grew its position in shares of Amdocs by 58.2% during the 3rd quarter. Blue Trust Inc. now owns 1,800 shares of the technology company’s stock valued at $157,000 after acquiring an additional 662 shares during the period. Raymond James & Associates increased its position in Amdocs by 9.5% in the third quarter. Raymond James & Associates now owns 501,104 shares of the technology company’s stock worth $43,837,000 after buying an additional 43,627 shares during the last quarter. Foundations Investment Advisors LLC bought a new position in Amdocs during the third quarter worth about $226,000. Finally, Tempus Wealth Planning LLC lifted its position in shares of Amdocs by 15.3% during the third quarter. Tempus Wealth Planning LLC now owns 4,842 shares of the technology company’s stock worth $424,000 after acquiring an additional 643 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

DOX has been the topic of a number of analyst reports. Barclays decreased their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday, November 14th. Oppenheimer lifted their price objective on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Finally, StockNews.com upgraded shares of Amdocs from a “buy” rating to a “strong-buy” rating in a report on Wednesday, February 5th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Amdocs currently has an average rating of “Buy” and a consensus target price of $101.20.

Read Our Latest Report on Amdocs

Amdocs Stock Performance

Shares of DOX opened at $89.55 on Wednesday. Amdocs Limited has a one year low of $74.41 and a one year high of $94.04. The firm has a market capitalization of $10.11 billion, a PE ratio of 20.78, a price-to-earnings-growth ratio of 1.41 and a beta of 0.71. The company has a 50-day simple moving average of $85.92 and a two-hundred day simple moving average of $86.49. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20.

Amdocs (NASDAQ:DOXGet Free Report) last released its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. On average, analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Sunday, April 20th. Shareholders of record on Monday, March 31st will be issued a $0.527 dividend. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.35%. Amdocs’s dividend payout ratio (DPR) is presently 48.72%.

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

See Also

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.